LRP4 Antibody-Associated Myasthenia Gravis: Distinct Clinical Phenotype and Treatment Challenges in the German MG Registry
This study reveals that LRP4 antibody-positive myasthenia gravis constitutes a distinct subgroup marked by higher disease severity and treatment escalation compared to other antibody-defined MG types, emphasizing its unique clinical management needs.